Kalshi Launches Prediction Markets for Clinical Trials and FDA Decisions

Kalshi to allow bets on clinical trials, FDA decisions

July 16 (Reuters) - Prediction market platform Kalshi will start taking bets on the outcomes of clinical trials and FDA regulatory reviews,

STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals

Prediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry could be next.

STAT+: Pharmalittle: We’re reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and more

Kalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory approvals

Kalshi to allow bets on clinical trials, FDA decisions

Kalshi Holds Early IPO Talks as Prediction Markets Gain Wall Street Traction

Kalshi has reportedly held early IPO talks as prediction-market revenue surges, showing how event contracts are moving toward Wall Street.

Kalshi launches 'Kalshi Pro' trading terminal for high-volume prediction market traders

The platform is designed to alleviate problems the company's most active traders have run into, according to a memo provided to CNBC.